Plain-English translation of NCT07224399 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing a new medication called , which is given as an injection under the skin. Researchers want to understand how the body absorbs and processes this medication, whether it's safe, and how well it works in people who are healthy but overweight or obese. The study will start with small doses and gradually increase them to find the right balance between benefit and safety.
Currently, there are limited treatment options for people who struggle with weight management. This medication represents a new approach to helping people achieve healthier weight, and this early-stage study is needed to make sure it's safe and effective before it can be tested in larger groups of patients.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will receive either the new medication or a placebo (a dummy injection with no active ingredient) as an injection under your skin. The study has two parts: in the first part, you'll receive a single injection and be monitored; in the second part, participants receive multiple injections over time. You'll have several clinic visits where doctors will check your health, draw blood, and ask about any side effects you experience. The entire study will last several weeks to a few months, depending on which group you're in.
AI-generated summary from trial data · Aug 9, 2026 · Not medical advice
United States